Franklin M. Berger

Director

Director at Retension Pharmaceuticals, Inc., filing insider transactions on 2026-10-13.

Total Purchases

$120K

1 transaction

Total Sales

—

0 transactions

Companies Traded

1

1 total filings

Active Since

2026-10-13

Last: 2026-10-13

Companies

Retension Pharmaceuticals, Inc.

Other Reporting Insiders at Retension Pharmaceuticals, Inc.

Eric L. Keller
Director & CHIEF EXECUTIVE OFFICER
Last filing 2026-10-13

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-10-13	RTSN	Purchase	10.0K	$12.00	$120K	10.0K	SEC ↗

Franklin M. Berger (Retension Pharmaceuticals, Inc.) Insider Trades | Tormere